Pacific Biosciences Of California reported $97.83M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Agilent USD 1.44B 9M Mar/2026
Bruker USD 813.2M 87.7M Mar/2026
Danaher USD 52.95B 47.61B Mar/2026
General Electric Aerospace USD 18.06B 7.11B Mar/2026
Illumina USD 852M 51M Mar/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
Pacific Biosciences Of California USD 97.83M 41.29M Dec/2025
Quidel USD 1.85B 1.09B Mar/2026
Revvity USD 628.34M 2.12M Mar/2026
Roche Holding CHF 21.01B 10.84B Dec/2025
Standard Biotools USD 45.72M 2.7M Dec/2025
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
Waters USD 1.12B 457.15M Mar/2026